Abstract
This review highlights in vitro drug dissolution/permeation methods available for topical and transdermal nanocarriers that have been designed to modulate the propensity of drug release, drug penetration into skin, and permeation into systemic circulation. Presently, a few of USFDA-approved in vitro dissolution/permeation methods are available for skin product testing with no specific application to nanocarriers. Researchers are largely utilizing the in-house dissolution/permeation testing methods of nanocarriers. These drug release and permeation methods are pending to be standardized. Their biorelevance with reference to in vivo plasma concentration–time profiles requires further exploration to enable translation of in vitro data for in vivo or clinical performance prediction.
Similar content being viewed by others
References
Hamblin M, Avci P, Prow T. Nanoscience in dermatology. 1st ed. Cambridge: Academic; 2016.
Abla MJ, Singh ND, Banga AK. Role of nanotechnology in skin delivery of drugs. In: Dragicevic N, Maibach H, editors. Percutaneous penetration enhancers chemical methods in penetration enhancement: nanocarriers. Berlin: Springer; 2016. p. 1–10.
Caster JM, Patel AN, Zhang T, Wang A. Investigational nanomedicines in 2016: a review of nanotherapeutics currently undergoing clinical trials. Interdiscip Rev Nanomed Nanobiotechnol. 2017;9(1):e1416. https://doi.org/10.1002/wnan.1416.
Williams AC. Transdermal and topical drug delivery. From theory to clinical practice. London: Pharmaceutical Press; 2003.
Ye C, Qiu H, Seixas MDG, Bazin R, Flament F, Cointereau-Chardon S, et al. Facial skin pores: a multiethnic study. Clin Cosmet Investig Dermatol. 2015;8:85. https://doi.org/10.2147/ccid.s74401.
Otberg N, Richter H, Schaefer H, Blume-Peytavi U, Sterry W, Lademann J. Variations of hair follicle size and distribution in different body sites. J Invest Dermatol. 2004;122(1):14–9. https://doi.org/10.1046/j.0022-202X.2003.22110.x.
Luengo J, Lehr C-M, Otberg N, Teichmann A, Blume-Peytavi U, Richter H, et al. Nanoparticles—an efficient carrier for drug delivery into the hair follicles. Eur J Pharm Biopharm. 2006;66(2):159–64. https://doi.org/10.1016/j.ejpb.2006.10.019.
Patzelt A, Mak WC, Jung S, Knorr F, Meinke MC, Richter H, et al. Do nanoparticles have a future in dermal drug delivery? J Control Release. 2017;246:174–82. https://doi.org/10.1016/j.jconrel.2016.09.015.
Nastiti CMRR, Ponto T, Abd E, Grice JE, Benson HAE, Roberts MS. Topical nano and microemulsions for skin delivery. Pharmaceutics. 2017;9(4):37. https://doi.org/10.3390/pharmaceutics9040037.
Delouise LA. Applications of nanotechnology in dermatology. J Invest Dermatol. 2012;132(3 PART 2):964–75. https://doi.org/10.1038/jid.2011.425.
Ng K, Lau W. Skin deep: the basics of human skin structure and drug penetration. In: Dragicevic N, Maibach H, editors. Percutaneous penetration enhancers chemical methods in penetration enhancement: drug manipulation strategies and vehicle effects. Berlin: Springer; 2015. p. 3–10. https://doi.org/10.1007/978-3-662-45013-0.
Baroli B. Penetration of nanoparticles and nanomaterials in the skin: fiction or reality? J Pharm Sci. 2010;99(1):21–50. https://doi.org/10.1002/jps.21817.
Grice JE, Moghimi HR, Ryan E, Zhang Q, Haridass I, Mohammed Y, et al. Non-formulation parameters that affect penetrant-skin-vehicle interactions and percutaneous absorption. In: Dragicevic N, Maibach H, editors. Percutaneous penetration enhancers drug penetration into/through the skin: methodology and general considerations. Berlin: Springer; 2017. p. 45–75. https://doi.org/10.1007/978-3-662-53270-6.
Surber C, Humbert P, Abels C, Maibach H. The acid mantle: a myth or an essential part of skin health? Curr Probl Dermatol. 2018;54:1–10. https://doi.org/10.1159/000489512.
Elias PM. Stratum corneum defensive functions: an integrated view. J Invest Dermatol. 2005;125(2):183–200. https://doi.org/10.1111/j.0022-202X.2005.23668.x.
Schmid-Wendtner MH, Korting HC. The pH of the skin surface and its impact on the barrier function. Skin Pharmacol Physiol. 2006;19(6):296–302. https://doi.org/10.1159/000094670.
Grice EA, Segre JA. The skin microbiome. Nat Rev Microbiol. 2011;9(4):244–53. https://doi.org/10.1038/nrmicro2537.
US Food and Drug Administration. Guidance for industry considering whether an FDA-regulated product involves the application of nanotechnology. 2014.
Rivera Gil P, Hühn D, del Mercato LL, Sasse D, Parak WJ. Nanopharmacy: inorganic nanoscale devices as vectors and active compounds. Pharmacol Res. 2010;62(2):115–25. https://doi.org/10.1016/j.phrs.2010.01.009.
Harjoh N, Wong T, Nawaz A, Khan N, Harun M. Nanocarriers and their actions to improve skin permeability and transdermal drug delivery. Curr Pharm Des. 2015;21(20):2848–66. https://doi.org/10.2174/1381612821666150428145216.
Chityal G, Poornachandra Y, Pombala S. Therapeutic nanomaterials: from a drug delivery perspective. In: Andronescu E, Grumezescu A, editors. Nanostructures for drug delivery. Amasterdam: Elsevier; 2017. p. 1–61.
Pardeike J, Hommoss A, Müller RH. Lipid nanoparticles (SLN, NLC) in cosmetic and pharmaceutical dermal products. Int J Pharm. 2009;366(1–2):170–84. https://doi.org/10.1016/j.ijpharm.2008.10.003.
Contri R, Fiel L, Pohlmann A, Guterres S, Beck R. Transport of substances and nanoparticles across the skin and in vitro models to evaluate skin permeation and/or penetration. In: Beck R, Guterres S, Pohlmann A, editors. Nanocosmetics and nanomedicines. Berlin: Springer; 2011. p. 3–36. https://doi.org/10.1007/978-3-642-19792-5.
Neubert RHH. Potentials of new nanocarriers for dermal and transdermal drug delivery. Eur J Pharm Biopharm. 2011;77(1):1–2. https://doi.org/10.1016/j.ejpb.2010.11.003.
Palmer BC, DeLouise LA. Nanoparticle-enabled transdermal drug delivery systems for enhanced dose control and tissue targeting. Molecules. 2016;21(12):1719. https://doi.org/10.3390/molecules21121719.
Vogt A, Lendlein A, Alexiev U, Neffe AT, Wischke C, Ma N. Nanocarriers for drug delivery into and through the skin—do existing technologies match clinical challenges? J Control Release. 2016;242:3–15. https://doi.org/10.1016/j.jconrel.2016.07.027.
Bibi N, Ahmed N, Khan G. Nanostructures in transdermal drug delivery systems. In: Andronescu E, Grumezescu A, editors. Nanostructures for drug delivery. Amsterdam: Elsevier; 2017. p. 639–68.
Bhatia S. Natural polymer drug delivery systems: nanoparticles, plants, and algae. Cham: Springer International Publishing; 2016.
Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12(11):991–1003. https://doi.org/10.1038/nmat3776.
D’Mello SR, Chen M-L, Lee SL, Cruz CN, Tyner KM, Kapoor M. The evolving landscape of drug products containing nanomaterials in the United States. Nat Nanotechnol. 2017;12(6):523–9. https://doi.org/10.1038/nnano.2017.67.
Abu Samah N, Heard C. The effects of topically applied polyNIPAM-based nanogels and their monomers on skin cyclooxygenase expression, ex vivo. Nanotoxicology. 2014;8(1):100–6. https://doi.org/10.3109/17435390.2012.754511.
Selzer D, Schaefer UF, Lehr CM, Hansen S. Basic mathematics in skin absorption. In: Dragicevic N, Maibach H, editors. Percutaneous penetration enhancers drug penetration into/through the skin: methodology and general considerations. Berlin: Springer; 2017. p. 3–25. https://doi.org/10.1007/978-3-662-53270-6_1.
Shah V, Skelly J. In vitro methodology: practical considerations in developing a quality control (in vitro release) procedure for topical drug products. In: Shah V, Maibach H, editors. Topical drug bioavailability, bioequivalence, and penetration. Boston: Springer; 1993. p. 107–16. https://doi.org/10.1007/978-1-4899-1262-6.
Dizaj S, Vazifehasl Z, Salatin S, Adibkia K, Javadzadeh Y. Nanosizing of drugs: effect on dissolution rate. Research in pharmaceutical sciences. Res Pharm Sci. 2015 [2019 Feb 28];10(2):95–108.
US Food and Drug Administration. Guidance for industry: drug products, including biological products, that contain nanomaterials. 2017.
Scheubel E. Predictive in vitro dissolution tools: application during formulation development. Clermont-Ferrand: Université d’Auvergne Clermont-Ferrand I; 2010.
Marques M, Ueda CT, Shah VP, Derdzinski K, Ewing G, Flynn G, et al. Topical and transdermal drug products. Pharmacopeial Forum. 2009;35(3):750–64.
Brown CK, Friedel HD, Barker AR, Buhse LF, Keitel S, Cecil TL, et al. FIP/AAPS joint workshop report: dissolution/in vitro release testing of novel/special dosage forms. Dissolut Technol. 2011;18(4):51–64. https://doi.org/10.1208/s12249-011-9634-x.
Chang R-K, Raw A, Lionberger R, Yu L. Generic development of topical dermatologic products: formulation development, process development, and testing of topical dermatologic products. AAPS J. 2013;15(1):41–52. https://doi.org/10.1208/s12248-012-9411-0.
Mansour H, Park C-W. Therapeutic applications and targeted delivery of nanomedicines and nanopharmaceutical products. In: Brenner S, editor. The clinical nanomedicine handbook. Boca Raton: CRC; 2013. p. 321–34.
Tinkle S, Mcneil SE, Mühlebach S, Bawa R, Borchard G, Barenholz YC, et al. Nanomedicines: addressing the scientific and regulatory gap. Ann N Y Acad Sci. 2014;1313(1):35–56. https://doi.org/10.1111/nyas.12403.
Weissig V, Pettinger T, Murdock N. Nanopharmaceuticals (part 1): products on the market. Int J Nanomedicine. 2014;9(1):4357–73. https://doi.org/10.2147/IJN.S46900.
Tadicherla S, Berman B. Percutaneous dermal drug delivery for local pain control. Ther Clin Risk Manag. 2006;2(1):99–113.
Praca F, Campos P, Eloy J, Petrilli R, Bentley M, Medina W. Topical photodynamic therapy for skin diseases: current status of preclinical and clinical research, nanocarriers and physical methods for photosensitizer delivery. In: Ascenso A, Simões S, Ribeiro H, editors. Carrier-mediated dermal delivery: applications in the prevention and treatment of skin disorders. Singapore: Pan Stanford; 2017.
Siewert M, Dressman J, Brown CK, Shah VP, Aiache J-M, Aoyagi N, et al. FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms. AAPS PharmSciTech. 2003;4(1):43–52. https://doi.org/10.1208/pt040107.
Copley T. Performance testing for topical and transdermal drug delivery. Am Pharm Rev. 2016:1–7.
D’Souza S. A review of in vitro drug release test methods for nano-sized dosage forms. Adv Pharm. 2014;2014:1–12. https://doi.org/10.1155/2014/304757.
Shen J, Burgess DJ. In vitro dissolution testing strategies for nanoparticulate drug delivery systems: recent developments and challenges. Drug Deliv Transl Res. 2013;3(5):409–15. https://doi.org/10.1007/s13346-013-0129-z.
Sabitha M, Sanoj R, Nair A, Lakshmanan V-K, Nair SV, Jayakumar R. Development and evaluation of 5-fluorouracil loaded chitin nanogels for treatment of skin cancer. Carbohydr Polym. 2013;91(1):48–57. https://doi.org/10.1016/J.CARBPOL.2012.07.060.
Khalil SKH, El-Feky GS, El-Banna ST, Khalil WA. Preparation and evaluation of warfarin-β-cyclodextrin loaded chitosan nanoparticles for transdermal delivery. Carbohydr Polym. 2012;90(3):1244–53. https://doi.org/10.1016/j.carbpol.2012.06.056.
Liu Y, Nguyen A, Allen A, Zoldan J, Huang Y, Chen JY. Regenerated cellulose micro-nano fiber matrices for transdermal drug release. Mater Sci Eng C. 2017;74:485–92. https://doi.org/10.1016/J.MSEC.2016.12.048.
Elmowafy M, Samy A, Abdelaziz AE, Shalaby K, Abdelgawad MA, Raslan MA, et al. Polymeric nanoparticles based topical gel of poorly soluble drug: formulation, ex-vivo and in vivo evaluation. Beni-Suef Univ J Basic Appl Sci. 2017;6(2):184–91. https://doi.org/10.1016/j.bjbas.2017.03.004.
Jug M, Hafner A, Lovrić J, Kregar ML, Pepić I, Vanić Ž, et al. An overview of in vitro dissolution/release methods for novel mucosal drug delivery systems. J Pharm Biomed Anal. 2018;147:350–66. https://doi.org/10.1016/j.jpba.2017.06.072.
Kelidari HR, Saeedi M, Akbari J, Morteza-Semnani K, Gill P, Valizadeh H, et al. Formulation optimization and in vitro skin penetration of spironolactone loaded solid lipid nanoparticles. Colloids Surf B Biointerfaces. 2015;128:473–9. https://doi.org/10.1016/j.colsurfb.2015.02.046.
Moazeni M, Kelidari HR, Saeedi M, Morteza-Semnani K, Nabili M, Gohar AA, et al. Time to overcome fluconazole resistant Candida isolates: solid lipid nanoparticles as a novel antifungal drug delivery system. Colloids Surf B Biointerfaces. 2016;142:400–7. https://doi.org/10.1016/j.colsurfb.2016.03.013.
Somagoni J, Patel AR, Boakye CHA, Singh M, Zucolotto V, Mendonca Faria HA, et al. Nanomiemgel—a novel drug delivery system for topical application—in vitro and in vivo evaluation. PLoS One. 2014;9(12):e115952. https://doi.org/10.1371/journal.pone.0115952.
Gupta S, Jayakumar R, Panonnummal R, Sabitha M, Divya G. Acitretin and aloe-emodin loaded chitin nanogel for the treatment of psoriasis. Eur J Pharm Biopharm. 2016;107:97–109. https://doi.org/10.1016/j.ejpb.2016.06.019.
Panonnummal R, Jayakumar R, Sabitha M. Comparative anti-psoriatic efficacy studies of clobetasol loaded chitin nanogel and marketed cream. Eur J Pharm Sci. 2017;96:193–206. https://doi.org/10.1016/j.ejps.2016.09.007.
Kaur A, Katiyar SS, Kushwah V, Jain S. Nanoemulsion loaded gel for topical co-delivery of clobitasol propionate and calcipotriol in psoriasis. Nanomedicine. 2017;13(4):1473–82. https://doi.org/10.1016/j.nano.2017.02.009.
Hua S. Comparison of in vitro dialysis release methods of loperamide-encapsulated liposomal gel for topical drug delivery. Int J Nanomedicine. 2014;9(1):735–44. https://doi.org/10.2147/IJN.S55805.
Noshi SH. Lipid-based drug delivery systems for the enhancement of topical delivery of benzocaine. J Pharm Biol Sci. 2018;13(3):13–9. https://doi.org/10.9790/3008-1303011319.
Hussain A, Samad A, Nazish I, Ahmed FJ. Nanocarrier-based topical drug delivery for an antifungal drug. Drug Dev Ind Pharm. 2014;40(4):527–41. https://doi.org/10.3109/03639045.2013.771647.
Sanap GS, Mohanta GP. Development of miconazole nitrate controlled release formulations based on SLN and NLC for topical delivery. Int J Pharm Pharm Sci. 2014;6(4):393–9.
Yang M, Gu Y, Yang D, Tang X, Liu J. Development of triptolide-nanoemulsion gels for percutaneous administration: physicochemical, transport, pharmacokinetic and pharmacodynamic characteristics. J Nanobiotechnology. 2017;15(1):88. https://doi.org/10.1186/s12951-017-0323-0.
Deva P. Nanoparticulate drug delivery systems, in vitro drug release test methods. Int J Pharma Bio Sci. 2017;8(3):103–19. https://doi.org/10.22376/ijpbs.2017.8.3.p103-119.
Jana S, Manna S, Nayak AK, Sen KK, Basu SK. Carbopol gel containing chitosan-egg albumin nanoparticles for transdermal aceclofenac delivery. Colloids Surf B Biointerfaces. 2014;114:36–44. https://doi.org/10.1016/j.colsurfb.2013.09.045.
Chen H, Wang Y, Zhai Y, Zhai G, Wang Z, Liu J. Development of a ropivacaine-loaded nanostructured lipid carrier formulation for transdermal delivery. Colloids Surf A Physicochem Eng Asp. 2015;465(465):130–6. https://doi.org/10.1016/j.colsurfa.2014.10.046.
Song J, Fan X, Shen Q. Daidzein-loaded nanostructured lipid carriers-PLGA nanofibers for transdermal delivery. Int J Pharm. 2016;501(1–2):245–52. https://doi.org/10.1016/j.ijpharm.2016.02.003.
Elgindy NA, Mehanna MM, Mohyeldin SM. Self-assembled nano-architecture liquid crystalline particles as a promising carrier for progesterone transdermal delivery. Int J Pharm. 2016;501(1–2):167–79. https://doi.org/10.1016/j.ijpharm.2016.01.049.
Dias SFL, Nogueira SS, De França DF, Guimarães MA, De Oliveira Pitombeira NA, Gobbo GG, et al. Acetylated cashew gum-based nanoparticles for transdermal delivery of diclofenac diethyl amine. Carbohydr Polym. 2016;143:254–61. https://doi.org/10.1016/j.carbpol.2016.02.004.
Ahmad A, Abuzinadah MF, Alkreathy HM, Banaganapalli B, Mujeeb M. Ursolic acid rich Ocimum sanctum L leaf extract loaded nanostructured lipid carriers ameliorate adjuvant induced arthritis in rats by inhibition of COX-1, COX-2, TNF-α and IL-1: pharmacological and docking studies. Davis KR, editor. PLoS One. 2018;13(3):e0193451. https://doi.org/10.1371/journal.pone.0193451.
Singh I, Saraf SA, Singh S, Saha S, Parashar P, Kanoujia J. Transdermal potential and anti-gout efficacy of febuxostat from niosomal gel. J Drug Deliv Sci Technol. 2017;39:348–61. https://doi.org/10.1016/j.jddst.2017.04.020.
Mohseni M, Ilka R, Mehravi B, Ashtari K, Abnoos M, Mousavi SAJ. Chitosan-alginate nano-carrier for transdermal delivery of pirfenidone in idiopathic pulmonary fibrosis. Int J Biol Macromol. 2018;118:1319–25. https://doi.org/10.1016/j.ijbiomac.2018.04.147.
Garg NK, Sharma G, Singh B, Nirbhavane P, Tyagi RK, Shukla R, et al. Quality by design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): an improved dermatokinetic profile for inflammatory disorder(s). Int J Pharm. 2017;517(1–2):413–31. https://doi.org/10.1016/j.ijpharm.2016.12.010.
Elmataeeshy ME, Sokar MS, Bahey-El-Din M, Shaker DS. Enhanced transdermal permeability of terbinafine through novel nanoemulgel formulation; development, in vitro and in vivo characterization. Future J Pharm Sci. 2018;4(1):18–28. https://doi.org/10.1016/j.fjps.2017.07.003.
Vaghasiya H, Kumar A, Sawant K. Development of solid lipid nanoparticles based controlled release system for topical delivery of terbinafine hydrochloride. Eur J Pharm Sci. 2013;49(2):311–22. https://doi.org/10.1016/j.ejps.2013.03.013.
Domínguez-Villegas V, Clares-Naveros B, García-López ML, Calpena-Campmany AC, Bustos-Zagal P, Garduño-Ramírez ML. Development and characterization of two nano-structured systems for topical application of flavanones isolated from Eysenhardtia platycarpa. Colloids Surf B Biointerfaces. 2014;116:183–92. https://doi.org/10.1016/j.colsurfb.2013.12.009.
Pople P, Singh K. Development and evaluation of topical formulation containing solid lipid nanoparticles of vitamin A. AAPS PharmSciTech. 2006;7(4):91–E69. https://doi.org/10.1208/pt070491.
Ng SF, Rouse J, Sanderson D, Eccleston G. A comparative study of transmembrane diffusion and permeation of ibuprofen across synthetic membranes using Franz diffusion cells. Pharmaceutics. 2010;2(2):209–23. https://doi.org/10.3390/pharmaceutics2020209.
Singh S, Singh M, Tripathi CB, Arya M, Saraf SA. Development and evaluation of ultra-small nanostructured lipid carriers: novel topical delivery system for athlete’s foot. Drug Deliv Transl Res. 2016;6(1):38–47. https://doi.org/10.1007/s13346-015-0263-x.
Teledyne Hanson Research. Vertical diffusion cell 6-cell manual diffusion test system. https://hansonresearch.com/diffusion-testing/manual-diffusion/. Accessed 14 Aug 2018.
de Lino MES, ALM R, Perissinato AG, Pereira GR, Mudrik PS. Evaluation of skin absorption of drugs from topical and transdermal formulations. Braz J Pharm Sci. 2016;52(3):527–44. https://doi.org/10.1590/s1984-82502016000300018.
Murthy SN, Hiremath SRR. Physical and chemical permeation enhancers in transdermal delivery of terbutaline sulphate. AAPS PharmSciTech. 2004;2(1):1–5. https://doi.org/10.1208/pt0201_tn1.
Fang JY, Fang CL, Liu CH, Su YH. Lipid nanoparticles as vehicles for topical psoralen delivery: solid lipid nanoparticles (SLN) versus nanostructured lipid carriers (NLC). Eur J Pharm Biopharm. 2008;70(2):633–40. https://doi.org/10.1016/j.ejpb.2008.05.008.
Calpena AC, Souto EB, Garduño-Ramirez ML, García ML, Clares B, Abrego G, et al. Nanoemulsions for dermal controlled release of oleanolic and ursolic acids: in vitro, ex vivo and in vivo characterization. Colloids Surf B Biointerfaces. 2015;130:40–7. https://doi.org/10.1016/j.colsurfb.2015.03.062.
Nawaz A, Wong TW. Chitosan-carboxymethyl-5-fluorouracil-folate conjugate particles: microwave modulated uptake by skin and melanoma cells. J Invest Dermatol. 2018;138(11):2412–22. https://doi.org/10.1016/j.jid.2018.04.037.
Khan NR, Wong TW. Microwave-aided skin drug penetration and retention of 5-fluorouracil-loaded ethosomes. Expert Opin Drug Deliv. 2016;13(9):1209–19. https://doi.org/10.1080/17425247.2016.1193152.
Khan NR, Wong TW. 5-Fluorouracil ethosomes—skin deposition and melanoma permeation synergism with microwave. Artif Cells Nanomed Biotechnol. 2018;46(sup1):568–77. https://doi.org/10.1080/21691401.2018.1431650.
Limón D, Amirthalingam E, Rodrigues M, Halbaut L, Andrade B, Garduño-Ramírez ML, et al. Novel nanostructured supramolecular hydrogels for the topical delivery of anionic drugs. Eur J Pharm Biopharm. 2015;96:421–36. https://doi.org/10.1016/j.ejpb.2015.09.007.
Al-Kassas R, Wen J, Cheng AEM, Kim AMJ, Liu SSM, Yu J. Transdermal delivery of propranolol hydrochloride through chitosan nanoparticles dispersed in mucoadhesive gel. Carbohydr Polym. 2016;153:176–86. https://doi.org/10.1016/j.carbpol.2016.06.096.
Nawaz A, Wong TW. Microwave as skin permeation enhancer for transdermal drug delivery of chitosan-5-fluorouracil nanoparticles. Carbohydr Polym. 2017;157:906–19. https://doi.org/10.1016/j.carbpol.2016.09.080.
Ahmed TA, El-Say KM. Development of alginate-reinforced chitosan nanoparticles utilizing W/O nanoemulsification/internal crosslinking technique for transdermal delivery of rabeprazole. Life Sci. 2014;110(1):35–43. https://doi.org/10.1016/j.lfs.2014.06.019.
Vijayan V, Reddy KR, Sakthivel S, Swetha C. Optimization and charaterization of repaglinide biodegradable polymeric nanoparticle loaded transdermal patchs: in vitro and in vivo studies. Colloids Surf B Biointerfaces. 2013;111:150–5. https://doi.org/10.1016/j.colsurfb.2013.05.020.
Aslam M, Aqil M, Ahad A, Najmi AK, Sultana Y, Ali A. Application of Box-Behnken design for preparation of glibenclamide loaded lipid based nanoparticles: optimization, in vitro skin permeation, drug release and in vivo pharmacokinetic study. J Mol Liq. 2016;219:897–908. https://doi.org/10.1016/j.molliq.2016.03.069.
Schneider M, Hirvonen J, Laaksonen T, Malinovskaja-Gomez K, Labouta HI. Transdermal iontophoresis of flufenamic acid loaded PLGA nanoparticles. Eur J Pharm Sci. 2016;89:154–62. https://doi.org/10.1016/j.ejps.2016.04.034.
Mennini N, Cirri M, Maestrelli F, Mura P. Comparison of liposomal and NLC (nanostructured lipid carrier) formulations for improving the transdermal delivery of oxaprozin: effect of cyclodextrin complexation. Int J Pharm. 2016;515(1–2):684–91. https://doi.org/10.1016/j.ijpharm.2016.11.013.
Santander-Ortega MJ, Stauner T, Loretz B, Ortega-Vinuesa JL, Bastos-González D, Wenz G, et al. Nanoparticles made from novel starch derivatives for transdermal drug delivery. J Control Release. 2010;141(1):85–92. https://doi.org/10.1016/j.jconrel.2009.08.012.
Joshi A, Kaur J, Kulkarni R, Chaudhari R. In-vitro and ex-vivo evaluation of raloxifene hydrochloride delivery using nano-transfersome based formulations. J Drug Deliv Sci Technol. 2018;45:151–8. https://doi.org/10.1016/j.jddst.2018.02.006.
Dutta K, Das B, Orasugh JT, Mondal D, Adhikari A, Rana D, et al. Bio-derived cellulose nanofibril reinforced poly(N-isopropylacrylamide)-g-guar gum nanocomposite: an avant-garde biomaterial as a transdermal membrane. Polymer. 2018;135:85–102. https://doi.org/10.1016/j.polymer.2017.12.015.
Fahmy UA, Aljaeid BM. Tadalafil transdermal delivery with alpha-lipoic acid self nanoemulsion for treatment of erectile dysfunction by diabetes mellitus. Int J Pharmacol. 2018;14(7):945–51. https://doi.org/10.3923/ijp.2018.945.951.
Zavgorodnya O, Penman AD, Bridges SL, Kharlampieva E, Carmona-Moran CA, Singh JA, et al. Development of gellan gum containing formulations for transdermal drug delivery: component evaluation and controlled drug release using temperature responsive nanogels. Int J Pharm. 2016;509(1–2):465–76. https://doi.org/10.1016/j.ijpharm.2016.05.062.
Saboktakin MR, Akhyari S, Nasirov FA. Synthesis and characterization of modified starch/polybutadiene as novel transdermal drug delivery system. Int J Biol Macromol. 2014;69:442–6. https://doi.org/10.1016/j.ijbiomac.2014.05.062.
Bose S, Du Y, Takhistov P, Michniak-Kohn B. Formulation optimization and topical delivery of quercetin from solid lipid based nanosystems. Int J Pharm. 2013;441(1–2):56–66. https://doi.org/10.1016/j.ijpharm.2012.12.013.
Tan JPK, Goh CH, Tam KC. Comparative drug release studies of two cationic drugs from pH-responsive nanogels. Eur J Pharm Sci. 2007;32(4–5):340–8. https://doi.org/10.1016/j.ejps.2007.08.010.
Mora L, Chumbimuni-Torres KY, Clawson C, Hernandez L, Zhang L, Wang J. Real-time electrochemical monitoring of drug release from therapeutic nanoparticles. J Control Release. 2009;140(1):69–73. https://doi.org/10.1016/j.jconrel.2009.08.002.
Wong TW, Nor KA. Physicochemical modulation of skin barrier by microwave for transdermal drug delivery. Pharm Res. 2013;30(1):90–103. https://doi.org/10.1007/s11095-012-0852-z.
Thermo Fisher Scientific USA. Slide-A-Lyzer™ MINI dialysis device, 10K MWCO, 2 mL https://www.thermofisher.com/order/catalog/product/88404. Accessed 20 Aug 2018.
Shahiwala A, Mehta T, Momin M. Parenteral drug delivery systems. In: Mishra A, Shahiwala A, editors. In-vitro and in-vivo tools in drug delivery research for optimum clinical outcomes. Florida: CRC; 2018.
Tan JPK, Tam KC. Application of drug selective electrode in the drug release study of pH-responsive microgels. J Control Release. 2007;118(1):87–94. https://doi.org/10.1016/j.jconrel.2006.11.017.
Rosenblatt KM, Douroumis D, Bunjes H. Drug release from differently structured monoolein/poloxamer nanodispersions studied with differential pulse polarography and ultrafiltration at low pressure. J Pharm Sci. 2007;96(6):1564–75. https://doi.org/10.1002/jps.20808.
Charalampopoulos N, Avgoustakis K, Kontoyannis CG. Differential pulse polarography: a suitable technique for monitoring drug release from polymeric nanoparticle dispersions. Anal Chim Acta. 2003;491(1):57–62. https://doi.org/10.1016/S0003-2670(03)00788-8.
Martin CA. Evaluating the utility of fiber optic analysis for dissolution testing of drug products. Dissolut Technol. 2003;10(4):37–9. https://doi.org/10.14227/DT100403P37.
Gray VA. Dissolution testing using fiber optics—a regulatory perspective. Dissolut Technol. 2003;10(4):33–6. https://doi.org/10.14227/DT100403P33.
Nir I, Lu X. In situ UV fiber optics for dissolution testing—what, why, and where we are after 30 years. Dissolution Technol. 2018;25(3):70–7. doi: https://doi.org/10.14227/DT250318P70
Guillot A, Limberge M, Krämer J, Lehr CM. In situ drug release monitoring with a fiber-optic system: overcoming matrix interferences using derivative spectrophotometry. Dissolut Technol. 2013;20(2):15–9. https://doi.org/10.14227/DT200213P15.
Uddin R, Saffoon N, Bishwajit S. Dissolution and dissolution apparatus: a review. Int J Curr Biomed Pharm Res. 2011;1(4):201–7. https://doi.org/10.1081/DDC-120021777.
Bijlani V, Yuonayel D, Katpally S, Chukwumezie BN, Adeyeye MC. Monitoring ibuprofen release from multiparticulates: in situ fiber-optic technique versus the HPLC method: a technical note. AAPS PharmSciTech. 2007;8(3):E9–12. https://doi.org/10.1208/pt0803052.
Voisine JM, Zolnik BS, Burgess DJ. In situ fiber optic method for long-term in vitro release testing of microspheres. Int J Pharm. 2008;356(1–2):206–11. https://doi.org/10.1016/J.IJPHARM.2008.01.017.
Liu L, Osei T, Hsu J, Greyling J. Evaluation of in-situ fiber optics dissolution method for compound A extended release tablets. Am Pharm Rev. 2011:1–9.
Romero EL, Morilla MJ. Ultradeformable phospholipid vesicles as a drug delivery system: a review. Res Rep Transderm Drug Deliv. 2015;4:55. https://doi.org/10.2147/rrtd.s50370.
Rizvi SAA, Saleh AM. Applications of nanoparticle systems in drug delivery technology. Saudi Pharm J. 2018;26(1):64–70. https://doi.org/10.1016/j.jsps.2017.10.012.
Jijie R, Barras A, Boukherroub R, Szunerits S. Nanomaterials for transdermal drug delivery: beyond the state of the art of liposomal structures. J Mater Chem B. 2017;5(44):8653–75. https://doi.org/10.1039/c7tb02529g.
Hoeller S, Sperger A, Valenta C. Lecithin based nanoemulsions: a comparative study of the influence of non-ionic surfactants and the cationic phytosphingosine on physicochemical behaviour and skin permeation. Int J Pharm. 2009;370(1–2):181–6. https://doi.org/10.1016/j.ijpharm.2008.11.014.
Klang V, Haberfeld S, Hartl A, Valenta C. Effect of γ-cyclodextrin on the in vitro skin permeation of a steroidal drug from nanoemulsions: impact of experimental setup. Int J Pharm. 2012;423(2):535–42. https://doi.org/10.1016/j.ijpharm.2011.11.037.
Raupach K, El-Hagin N, Valenta C, Klang V, Matsko N. Development of sucrose stearate-based nanoemulsions and optimisation through γ-cyclodextrin. Eur J Pharm Biopharm. 2011;79(1):58–67. https://doi.org/10.1016/j.ejpb.2011.01.010.
Biondi M, Cilurzo F, Campani V, De Rosa G, Mayol L, Pitaro M. Development of nanoemulsions for topical delivery of vitamin K1. Int J Pharm. 2016;511(1):170–7. https://doi.org/10.1016/j.ijpharm.2016.07.004.
Qi T, Qi-lu L, Guang-xi Z, Yan-wei X, Chen-yu G, Chun-fen Y, et al. Development of a quercetin-loaded nanostructured lipid carrier formulation for topical delivery. Int J Pharm. 2012;430(1–2):292–8. https://doi.org/10.1016/j.ijpharm.2012.03.042.
Zheng Y, Syed S, Hao C-S, Wang B-Z, Ouyang W-Q, Wei Y-P, et al. Effects of Carbopol® 934 proportion on nanoemulsion gel for topical and transdermal drug delivery: a skin permeation study. Int J Nanomedicine. 2016;11:5971–87. https://doi.org/10.2147/ijn.s119286.
Mazumder B, Ray S, Kaurav S, Ghosh S, Dasgupta S. In vitro & in vivo studies on lornoxicam loaded nanoemulsion gels for topical application. Curr Drug Deliv. 2014;11(1):132–8. https://doi.org/10.2174/15672018113106660063.
Kim BS, Won M, Lee KM, Kim CS. In vitro permeation studies of nanoemulsions containing ketoprofen as a model drug. Drug Deliv. 2008;15(7):465–9. https://doi.org/10.1080/10717540802328599.
Hussain Z, Katas H, Mohd Amin MCI, Kumolosasi E, Buang F, Sahudin S. Self-assembled polymeric nanoparticles for percutaneous co-delivery of hydrocortisone/hydroxytyrosol: an ex vivo and in vivo study using an NC/Nga mouse model. Int J Pharm. 2013;444(1–2):109–19. https://doi.org/10.1016/j.ijpharm.2013.01.024.
Akbari J, Saeedi M, Morteza-Semnani K, Rostamkalaei SS, Asadi M, Asare-Addo K, et al. The design of naproxen solid lipid nanoparticles to target skin layers. Colloids Surf B Biointerfaces. 2016;145:626–33. https://doi.org/10.1016/j.colsurfb.2016.05.064.
Abdel-Hafez SM, Hathout RM, Sammour OA. Tracking the transdermal penetration pathways of optimized curcumin-loaded chitosan nanoparticles via confocal laser scanning microscopy. Int J Biol Macromol. 2018;108:753–64. https://doi.org/10.1016/j.ijbiomac.2017.10.170.
Joshi SA, Jalalpure SS, Kempwade AA, Peram MR. Fabrication and in-vivo evaluation of lipid nanocarriers based transdermal patch of colchicine. J Drug Deliv Sci Technol. 2017;41:444–53. https://doi.org/10.1016/j.jddst.2017.08.013.
Anirudhan TS, Nair AS, Bino SJ. Nanoparticle assisted solvent selective transdermal combination therapy of curcumin and 5-flurouracil for efficient cancer treatment. Carbohydr Polym. 2017;173:131–42. https://doi.org/10.1016/j.carbpol.2017.05.045.
Ravikumar R, Ganesh M, Senthil V, Ramesh YV, Jakki SL, Choi EY. Tetrahydro curcumin loaded PCL-PEG electrospun transdermal nanofiber patch: preparation, characterization, and in vitro diffusion evaluations. J Drug Deliv Sci Technol. 2018;44:342–8. https://doi.org/10.1016/j.jddst.2018.01.016.
Ahmed TA, El-Say KM, Aljaeid BM, Fahmy UA, Abd-Allah FI. Transdermal glimepiride delivery system based on optimized ethosomal nano-vesicles: preparation, characterization, in vitro, ex vivo and clinical evaluation. Int J Pharm. 2016;500(1–2):245–54. https://doi.org/10.1016/j.ijpharm.2016.01.017.
Lin WJ, Duh YS. Nanostructured lipid carriers for transdermal delivery of acid labile lansoprazole. Eur J Pharm Biopharm. 2016;108:297–303. https://doi.org/10.1016/j.ejpb.2016.07.015.
Tsai MJ, Lu IJ, Fu YS, Fang YP, Huang YB, Wu PC. Nanocarriers enhance the transdermal bioavailability of resveratrol: in-vitro and in-vivo study. Colloids Surf B Biointerfaces. 2016;148:650–6. https://doi.org/10.1016/j.colsurfb.2016.09.045.
Aqil M, Moghaddam AA, Ahmad FJ, Ali A, Ahad A, Sultana Y. Ibuprofen loaded nano-ethanolic liposomes carbopol gel system: in vitro characterization and anti-inflammatory efficacy assessment in Wistar rats. J Polym Eng. 2017;38(3):291–8. https://doi.org/10.1515/polyeng-2016-0462.
Setya S, Razdan BK, Talegaonkar S, Tariq M, Madaan T. Appraisal of transdermal water-in-oil nanoemulgel of selegiline HCl for the effective management of Parkinson’s disease: pharmacodynamic, pharmacokinetic, and biochemical investigations. AAPS PharmSciTech. 2018;19(2):573–89. https://doi.org/10.1208/s12249-017-0868-0.
Abdulbaqi IM, Darwis Y, Assi RA, Khan NAK. Transethosomal gels as carriers for the transdermal delivery of colchicine: statistical optimization, characterization, and ex vivo evaluation. Drug Des Devel Ther. 2018;12:795–813. https://doi.org/10.2147/DDDT.S158018.
Kaur A, Bhoop BS, Chhibber S, Sharma G, Gondil VS, Katare OP. Supramolecular nano-engineered lipidic carriers based on diflunisal-phospholipid complex for transdermal delivery: QbD based optimization, characterization and preclinical investigations for management of rheumatoid arthritis. Int J Pharm. 2017;533(1):206–24. https://doi.org/10.1016/j.ijpharm.2017.09.041.
Takeuchi I, Suzuki T, Makino K. Skin permeability and transdermal delivery route of 50-nm indomethacin-loaded PLGA nanoparticles. Colloids Surf B Biointerfaces. 2017;159:312–7. https://doi.org/10.1016/j.colsurfb.2017.08.003.
Qumbar M, Ameeduzzafar, Imam SS, Ali J, Ahmad J, Ali A. Formulation and optimization of lacidipine loaded niosomal gel for transdermal delivery: in-vitro characterization and in-vivo activity. Biomed Pharmacother. 2017;93:255–66. https://doi.org/10.1016/j.biopha.2017.06.043.
Sintov AC, Levy HV, Greenberg I. Continuous transdermal delivery of L-DOPA based on a self-assembling nanomicellar system. Pharm Res. 2017;34(7):1459–68. https://doi.org/10.1007/s11095-017-2162-y.
Arafa MG, Ayoub BM. DOE optimization of nano-based carrier of pregabalin as hydrogel: new therapeutic & chemometric approaches for controlled drug delivery systems. Sci Rep. 2017;7(1):41503. https://doi.org/10.1038/srep41503.
Xu H, Liu J, Yang X, Ni Q, Chen H, Hu W. Isotretinoin-loaded solid lipid nanoparticles with skin targeting for topical delivery. Int J Pharm. 2006;328(2):191–5. https://doi.org/10.1016/j.ijpharm.2006.08.007.
Trotta M, Peira E, Debernardi F, Gallarate M. Elastic liposomes for skin delivery of dipotassium glycyrrhizinate. Int J Pharm. 2002;241(2):319–27. https://doi.org/10.1016/S0378-5173(02)00266-1.
Alvarez-Román R, Naik A, Kalia YN, Guy RH, Fessi H. Enhancement of topical delivery from biodegradable nanoparticles. Pharm Res. 2004;21(10):1818–25. https://doi.org/10.1023/B:PHAM.0000045235.86197.ef.
Habib BA, Sayed S, Elsayed GM. Enhanced transdermal delivery of ondansetron using nanovesicular systems: fabrication, characterization, optimization and ex-vivo permeation study—Box-Cox transformation practical example. Eur J Pharm Sci. 2018;115:352–61. https://doi.org/10.1016/j.ejps.2018.01.044.
Pireddu R, Sinico C, Ennas G, Schlich M, Valenti D, Murgia S, et al. The effect of diethylene glycol monoethyl ether on skin penetration ability of diclofenac acid nanosuspensions. Colloids Surf B Biointerfaces. 2018;162:8–15. https://doi.org/10.1016/j.colsurfb.2017.11.012.
Ahad A, Al-Saleh AA, Al-Mohizea AM, Al-Jenoobi FI, Raish M, Yassin AEB, et al. Formulation and characterization of novel soft nanovesicles for enhanced transdermal delivery of eprosartan mesylate. Saudi Pharm J. 2017;25(7):1040–6. https://doi.org/10.1016/j.jsps.2017.01.006.
Alomrani AH, Badran MM. Flexosomes for transdermal delivery of meloxicam: characterization and antiinflammatory activity. Artif Cells Nanomed Biotechnol. 2017;45(2):305–12. https://doi.org/10.3109/21691401.2016.1147452.
Imam SS, Ahad A, Aqil M, Akhtar M, Sultana Y, Ali A. Formulation by design based risperidone nano soft lipid vesicle as a new strategy for enhanced transdermal drug delivery: in-vitro characterization, and in-vivo appraisal. Mater Sci Eng C. 2017;75:1198–205. https://doi.org/10.1016/j.msec.2017.02.149.
Butani D, Yewale C, Misra A. Topical amphotericin B solid lipid nanoparticles: design and development. Colloids Surf B Biointerfaces. 2016;139:17–24. https://doi.org/10.1016/j.colsurfb.2015.07.032.
Meng S, Zhang C, Shi W, Zhang X, Liu D, Wang P, et al. Preparation of osthole-loaded nano-vesicles for skin delivery: characterization, in vitro skin permeation and preliminary in vivo pharmacokinetic studies. Eur J Pharm Sci. 2016;92:49–54. https://doi.org/10.1016/j.ejps.2016.04.033.
Liu T, Niu X, Sun Q, Zhu Y, Wang XH, Wang L, et al. Evaluation of paeonol-loaded transethosomes as transdermal delivery carriers. Eur J Pharm Sci. 2017;99:240–5. https://doi.org/10.1016/j.ejps.2016.12.026.
Delgado-Charro MB, Guy RH. Effective use of transdermal drug delivery in children. Adv Drug Deliv Rev. 2014;73:63–82. https://doi.org/10.1016/j.addr.2013.11.014.
Michniak BB, Meidan V, Al-Khalili M, Wertz PW. Skin: physiology and penetration pathways. In: Meyer R, editor. Delivery system handbook for personal care and cosmetic products. Waltham: William Andrew-Elsevier; 2005. p. 77–100.
Cázares-Delgadillo J, Naik A, Kalia YN, Quintanar-Guerrero D, Ganem-Quintanar A. Skin permeation enhancement by sucrose esters: a pH-dependent phenomenon. Int J Pharm. 2005;297(1–2):204–12. https://doi.org/10.1016/j.ijpharm.2005.03.020.
Nair MK, Chetty DJ, Ho H, Chien YW. Biomembrane permeation of nicotine: mechanistic studies with porcine mucosae and skin. J Pharm Sci. 1997;86(2):257–62. https://doi.org/10.1021/js960095w.
Zorin S, Kuylenstierna F, Thulin H. In vitro test of nicotine’s permeability through human skin. Risk evaluation and safety aspects. Ann Occup Hyg. 1999;43(6):405–13. https://doi.org/10.1016/S0003-4878(99)00030-7.
Heard CM, Johnson S, Moss G, Thomas CP. In vitro transdermal delivery of caffeine, theobromine, theophylline and catechin from extract of guarana, Paullinia cupana. Int J Pharm. 2006;317(1):26–31. https://doi.org/10.1016/j.ijpharm.2006.02.042.
Chen L, Han L, Lian G. Recent advances in predicting skin permeability of hydrophilic solutes. Adv Drug Deliv Rev. 2013;65(2):295–305. https://doi.org/10.1016/j.addr.2012.05.001.
Lehman PA, Raney SG, Franz TJ. Percutaneous absorption in man: in vitro-in vivo correlation. Skin Pharmacol Physiol. 2011;24(4):224–30. https://doi.org/10.1159/000324884.
Williams AC, Barry BW. Penetration enhancers. Adv Drug Deliv Rev. 2012;64(SUPPL):128–37. https://doi.org/10.1016/j.addr.2012.09.032.
Azarmi S, Roa W, Löbenberg R. Current perspectives in dissolution testing of conventional and novel dosage forms. Int J Pharm. 2007;328(1 SPEC. ISS):12–21. https://doi.org/10.1016/j.ijpharm.2006.10.001.
Gillet A, Evrard B, Piel G. Liposomes and parameters affecting their skin penetration behaviour. J Drug Deliv Sci Technol. 2011;21(1):35–42. https://doi.org/10.1016/S1773-2247(11)50004-8.
Organisation for Economic Co-operation and Development (OECD). Joint meeting of the chemicals committee and the working party on chemicals, pesticides and biotechnology guidance notes on dermal absorption series on testing and assessment no. 156. ENV/JM/MONO(2011)36. 2011. https://www.oecd.org/chemicalsafety/testing/48532204.pdf. Accessed 10 Nov 2018.
Sartorelli P, Andersen HR, Angerer J, Corish J, Drexler H, Göen T, et al. Percutaneous penetration studies for risk assessment. Environ Toxicol Pharmacol. 2000;8(2):133–52. https://doi.org/10.1016/S1382-6689(00)00035-1.
Bronaugh R. Methods for in vitro percutaneous absorption. In: Zhai H, Maibach H, editors. Dermatotoxicology. New York: CRC; 2004. p. 520–6.
Roussel L, Abdayem R, Gilbert E, Pirot F, Haftek M. Influence of excipients on two elements of the stratum corneum barrier: intercellular lipids and epidermal tight junctions. In: Percutaneous penetration enhancers chemical methods in penetration enhancement: drug manipulation strategies and vehicle effects. Berlin: Springer; 2015. p. 69–92. https://doi.org/10.1007/978-3-662-45013-0_7.
Duan J, Seo P, Shah H, Suarez-Sharp S, Li M. Regulatory experience with in vivo in vitro correlations (IVIVC) in new drug applications. AAPS J. 2016;18(6):1379–90. https://doi.org/10.1208/s12248-016-9966-2.
Park K. Translation from mouse to human: time to think in new boxes. J Control Release. 2014;189:187. https://doi.org/10.1016/j.jconrel.2014.07.046.
Cardot JM, Beyssac E, Alric M. In vitro–in vivo correlation: importance of dissolution in IVIVC. Dissolut Technol. 2007;14(1):15–9. https://doi.org/10.14227/DT140107P15.
Sakore S, Chakraborty B. In vitro-in vivo correlation (IVIVC): a strategic tool in drug development. J Bioequiv Availab. 2011;8(4). https://doi.org/10.4172/jbb.S3-001.
Kumar R, Nagarwal RC, Dhanawat M, Pandit JK. In-vitro and in-vivo study of indomethacin loaded gelatin nanoparticles. J Biomed Nanotechnol. 2011;7(3):325–33. https://doi.org/10.1166/jbn.2011.1290.
Cao X, Deng WW, Fu M, Wang L, Tong SS, Wei YW, et al. In vitro release and in vitro-in vivo correlation for silybin meglumine incorporated into hollow-type mesoporous silica nanoparticles. Int J Nanomedicine. 2012;7:753–62. https://doi.org/10.2147/IJN.S28348.
Tiwari R, Pathak K. Nanostructured lipid carrier versus solid lipid nanoparticles of simvastatin: comparative analysis of characteristics, pharmacokinetics and tissue uptake. Int J Pharm. 2011;415(1–2):232–43. https://doi.org/10.1016/j.ijpharm.2011.05.044.
Huang Q, Li XM, Wei P, Wang Y, Chen B, Chen W, et al. Study on the release of fenofibrate nanosuspension in vitro and its correlation with in situ intestinal and in vivo absorption kinetics in rats. Drug Dev Ind Pharm. 2014;40(7):972–9. https://doi.org/10.3109/03639045.2013.794828.
Pavurala N, Khan MA, Krishnaiah YSR, Yang Y, Manda P. Development and validation of in vitro–in vivo correlation (IVIVC) for estradiol transdermal drug delivery systems. J Control Release. 2015;210:58–66. https://doi.org/10.1016/j.jconrel.2015.05.263.
Tirumalasetty PP, Mutalik S, Pillai R, Kondamudi PK, Malayandi R. Lidocaine transdermal patch: pharmacokinetic modeling and in vitro-in vivo correlation (IVIVC). AAPS PharmSciTech. 2016;17(3):588–96. https://doi.org/10.1208/s12249-015-0390-1.
Yan K, Yan T, Guo H, Li J, Wei L. Evaluation of transdermal permeability of pentoxifylline gel: in vitro skin permeation and in vivo microdialysis using Wistar rats. Drug Discov Ther. 2007;1(1):78–83.
Shen J, Burgess DJ. In vitro-in vivo correlation for complex non-oral drug products: where do we stand? J Control Release. 2015;219:644–51. https://doi.org/10.1016/j.jconrel.2015.09.052.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
The authors declare that they have no conflict of interest.
Additional information
Guest Editor: Sandra Klein
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Sheshala, R., Anuar, N.K., Abu Samah, N.H. et al. In Vitro Drug Dissolution/Permeation Testing of Nanocarriers for Skin Application: a Comprehensive Review. AAPS PharmSciTech 20, 164 (2019). https://doi.org/10.1208/s12249-019-1362-7
Received:
Accepted:
Published:
DOI: https://doi.org/10.1208/s12249-019-1362-7